NCT04310020 2026-03-17
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
M.D. Anderson Cancer Center
Sichuan University
Massachusetts General Hospital
Maastricht Radiation Oncology
University of Washington
SCRI Development Innovations, LLC
H. Lee Moffitt Cancer Center and Research Institute
Peking University People's Hospital
Alliance for Clinical Trials in Oncology
Stanford University